Breaking Finance News

A statement released earlier today by Commerzbank AG about JENOPTIK (ETR:JEN) bumps the target price to 16.50EUR

Boasting a price of 15.85EUR, JENOPTIK (ETR:JEN) traded 0.00% even on the day. With the last stock price close up 0.00% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. JENOPTIK has recorded a 50-day average of 0.00EUR and a two hundred day average of 0.00EUR. Volume of trade held steady, with 0 shares of JEN changing hands on par with the typical 0

Commerzbank AG bumped up the target of JENOPTIK (ETR:JEN) to 16.50EUR stating a potential upside of 0.04%.

On 9/21/2016, Commerzbank AG released a statement for JENOPTIK (ETR:JEN) bumped up the target price from 0.00EUR to 16.50EUR that suggested an upside of 0.04%.

See Chart Below


JENOPTIK has a with a one year low of 0.00EUR and a one year high of 0.00EUR JEN’s total market value is presently 0 EUR.

Brief Synopsis About JENOPTIK (ETR:JEN)

Jenoptik AG is a Germany-based company engaged in the field of optoelectronics. The group's activities are divided into three segments: Optics & Life Science, Mobility and Defense & Civil Systems. In the Optics & Life Science segment, the Company specializes in the development and manufacture of micro-optics, optoelectronic modules as well as integrated solutions. In the Mobility segment the Company offers optical, tactile and pneumatic metrology and laser machines for plastic and metal processing in the automotive industry, as well as systems for the detection of traffic violations, such as speed measurement and red light monitoring systems, including traffic service provision. The focus areas of the Defense & Civil Systems segment are mechatronic and sensor systems for civil and military applications. Its customers mainly include companies in the semiconductor equipment manufacturing, automotive industry, healthcare, security and defense technology as well as the aviation industry.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.